Pulmonary fibrosis is a progressive interstitial lung disease with a mean survival of 3-5 yrs. The underlying cause or genetic factors involved in the pathogenesis of idiopathic pulmonary fibrosis (IPF) are unknown. Thus, little practical improvement has been made in treatment. While genetic changes are reported in two genes that regulate telomerase activity, these occur in only a small subset of individuals and clearly do not represent the majority of the patients with this disease. MicroRNAs (miRNA, miR) are regulatory RNAs that regulate gene expression by targeting mRNAs for degradation or preventing protein translation. It has been estimated that a single miRNA can regulate the expression of 20-30 proteins. The miR-17~92 miRNA cluster targets genes, such as metalloproteinases, collagen, and transforming growth factor that are highly expressed in IPF. Our preliminary data indicate that there are decreases in expression of the miR-17~92 miRNA cluster in the lungs from patients with IPF. We hypothesize that decrease expression of miRNAs contained within this cluster are critical for the pathogenesis of IPF. In this proposal, we will investigate the specific role of this miRNA cluster. We will also explore which members of this cluster are critical in the development and progression of IPF. Lastly, we determine if intervention in murine models of pulmonary fibrosis to replete the cluster can be effective treatment of this disease. For these goals we plan to investigate the following specific aims:
Specific Aim 1 : Determine the mechanisms and cell types involved in miR-17~92 suppression in IPF.
Specific Aim 2 : To define the impact of manipulating miR-17~92 cluster on cellular phenotype and gene expression in cells from patients with IPF.
Specific Aim 3 : To define the effect of manipulating miR-17~92 expression in a murine model of pulmonary fibrosis.

Public Health Relevance

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with unknown etiology and a mean survival of 3-5 years survival. Despite ongoing studies to define the etiology of the disease, little practical improvement has been made in treatment and expected or observed outcomes. Complexity of IPF suggests that there are likely numerous interactions between a person's genes and environment. We speculate that searching for gene networks altered in patients with IPF would be a better approach to understand the disease. Since microRNAs can regulate multiple genes, we will focus on gene regulation through microRNAs in this proposal. We will use the integrative field of systems biology to classify and define molecular networks activated in these patients using miRNA and mRNA profiling of lung tissue. These data will be used to construct and predict gene networks that are activated in these patients to determine if the alterations can be used to classify and predict disease progression and severity as well as identify targets for therapeutic purposes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL102464-03
Application #
8255503
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Eu, Jerry Pc
Project Start
2010-05-01
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
3
Fiscal Year
2012
Total Cost
$377,438
Indirect Cost
$129,938
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Schilter, Heidi; Cantemir-Stone, Carmen Z; Leksa, Vladimir et al. (2015) The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-?1 pathway in human lung fibroblasts. Immunol Lett 165:90-101
Moldovan, Leni; Batte, Kara E; Trgovcich, Joanne et al. (2014) Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 18:371-90
Voorhees, Jeffrey L; Powell, Nicole D; Moldovan, Leni et al. (2013) Chronic restraint stress upregulates erythropoiesis through glucocorticoid stimulation. PLoS One 8:e77935
Voorhees, Jeffrey L; Tarr, Andrew J; Wohleb, Eric S et al. (2013) Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10. PLoS One 8:e58488
Dakhlallah, Duaa; Batte, Kara; Wang, Yijie et al. (2013) Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 187:397-405
Fischer, Sara N; Johnson, Jed K; Baran, Christopher P et al. (2011) Organ-derived coatings on electrospun nanofibers as ex vivo microenvironments. Biomaterials 32:538-46
Wang, Yijie; Wang, Hongmei; Piper, Melissa G et al. (2010) sRAGE induces human monocyte survival and differentiation. J Immunol 185:1822-35